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A B S T R A C T
The developmental processes that establish the synaptic architecture of the brain while retaining
capacity for activity-dependent remodeling, are complex and involve a combination of genetic and
epigenetic inﬂuences. Dysregulation of these processes can lead to problems with neural circuitry which
manifest in humans as a range of neurodevelopmental syndromes, such as schizophrenia, bipolar
disorder and fragile X mental retardation. Recent studies suggest that prenatal, postnatal and
intergenerational environmental factors play an important role in the aetiology of stress-related
psychopathology. A number of these disorders have been shown to display epigenetic changes in the
postmortem brain that reﬂect early life experience. These changes affect the regulation of gene
expression though chromatin remodeling (transcriptional) and post-transcriptional inﬂuences,
especially small noncoding microRNA (miRNA). These dynamic and inﬂuential molecules appear to
play an important function in both brain development and its adaption to stress. In this review, we
examine the role of miRNA in mediating the brain’s response to both prenatal and postnatal
environmental perturbations and explore how stress- induced alterations in miRNA expression can
regulate the stress response via modulation of the immune system. Given the close relationship between
environmental stress, miRNA, and brain development/function, we assert that miRNA hold a signiﬁcant
position at the molecular crossroads between neural development and adaptations to environmental
stress. A greater understanding of the dynamics that mediate an individual’s predisposition to stress-
induced neuropathology has major human health beneﬁts and is an important area of research.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The adult brain is an incredibly complex organ comprising many
different cells types with an astonishing capability for intercellular
connectivity. This is utilized to generate even more complicated
networks with the capacity to integrate neural input through
synapses and synaptic plasticity to form, maintain and modify
circuits. These circuits provide the neural basis for sensation,
cognition, memory and motivation. The organisation of this
assembly at the molecular level is no less complex and involves
many layers of gene regulation. At the transcriptional level there is a
myriad of epigenetic inﬂuences on chromatin structure including
DNA methylation and histone modiﬁcations that modify the
synthesis of RNA. This however, is just the beginning of mRNA’s
journey that will take it from the nucleus out into the cytoplasm to a
discrete site of translation or interaction point. The intracellular
trafﬁc and fate of RNA is highly organized by ribonucleoprotein
complexes and small non-coding RNAs. As relative newcomers on
this scene, miRNAs are small non-coding RNAs (22 nucleotides)
that post- transcriptionally modulate gene expression by either
repressing translation or inducing degradation of mRNA. MiRNAs are
abundant in the human brain and display a diverse range of
regulatory functions in the central nervous system (CNS). One role
emerging for miRNAs is in the cellular response to stress. These
molecules and their extensive gene networks provide a mechanism
to both drive important developmental initiatives and maintain
system homeostasis. This later feature, in particular, comes to the
fore at times of environmental adversity and may be modifying the
system dynamics to provide the most appropriate conditions to
buffer against cellular crisis.
The activation of the stress response by the CNS is necessary to
maintain health and homeostasis, however, there are also con-
sequences as these mechanisms can induce signiﬁcant changes in
neural structure and functionthat lead tothe developmentof a broad
range of psychopathology. One of the manifestations of this response
is stress-induced neuronal atrophy (dendritic retraction) in key brain
regions implicated in “depressive illness” (Christian et al., 2011; Cook
and Wellman, 2004). Environmental stressors may be physiological,
such as through exposure to toxins, pathogens, or nutrient
deprivation; or psychological, occurring when we face a situation
deemed to exceed our potential for coping. Both types of stress
produce physiological and psychological responses, such as elevated
blood pressure, elevated corticosteroids and deﬁcits in sustained
attention (reviewed by Evans and Cohen, 1987).In particular, exposure to environmental stressors can bring
about changes in expression of genes involved in the modulation of
miRNA expression, as well as changes in expression of miRNA
involved in the development and function of the CNS (Conaco et al.,
2006; Uchida et al., 2010; Wiesen and Tomasi, 2009). This may be
reﬂected in changes to the brain observed following stress
exposure such as region-speciﬁc increases in microglia (Tynan
et al., 2010); microglial and glutamatergic pyramidal neuron
activation (Hinwood et al., 2011a,b; Tynan et al., 2010); dendritic
retraction (Brown et al., 2005; Christian et al., 2011; Cook and
Wellman, 2004; Martin and Wellman, 2011) and cognitive deﬁcits
(Hinwood et al., 2011a,b; Wei et al., 2007). Indeed, changes in
miRNA expression levels are linked to neurodegeneration
(reviewed by Nelson et al. (2008)), with recent evidence
supporting a role for the dysregulation of miRNA expression in
psychiatric and neurological disorders (Beveridge and Cairns,
2012; Geaghan and Cairns, 2014; Miller and Wahlestedt, 2010).
2. MiRNA biogenesis and function
MiRNA biogenesis is a two-compartment process (Fig. 1)
beginning in the nucleus, with the transcription of primary
(pri-) miRNAs by RNA polymerase II (pol II). The pri-miRNAs are 50
capped and poly-adenylated, can be several kilobases long and may
comprise of one (monocistronic) or several (polycistronic) miRNA
precursors (Lee et al., 2002). The stem- loop (hairpin) structure is
recognized by DGCR8 (DiGeorge syndrome critical region gene 8),
which then docks with the RNase-III enzyme Drosha to form what
is known as the Microprocessor complex (Gregory et al., 2006).
Upon guidance by DGCR8, Drosha cleaves the stems to release the
precursor (pre-) miRNA, hairpins of 70 nucleotides with a two-
nucleotide overhang at the 30 end and 30 hydroxyl and 50 phosphate
groups (Han et al., 2004; Lee et al., 2003, 2002). Pre-miRNAs are
transferred to the cytoplasm by exportin-5 where they are further
cleaved by Dicer, another RNase-III family member, to yield the
mature, double-stranded duplex (18-25 nucleotides), consisting
of the antisense, or guide strand (miRNA) and a sense, or passenger
strand (Lee et al., 2002; Yi et al., 2003). The guide strand becomes
integrated with proteins from the Argonaut (Ago) family to form
the RNA-Induced Silencing Complex, or RISC (Gregory et al., 2005;
Preall et al., 2006; Siomi and Siomi, 2009). As either strand can be
incorporated into the RISC, miRNA derived from the 50 arm or 30
arm of the precursor are denoted by a -5p or -3p postscript
respectively (Alexiou et al., 2010). The miRNA ‘activated’ RISC then
Fig. 1. MicroRNA biogenesis In the nucleus, pri-miRNAs are transcribed by RNA polymerase II (Pol II), and may comprise of one (monocistronic) or several (polycistronic) 50
capped and poly-adenylated miRNA precursors (hairpin loop structures). Following transcription, the pri-miRNA stem-loop structure is cleaved by the DROSHA-DGCR8
microprocessor complex to release the pre-miRNA, which is then transferred to the cytoplasm by exportin 5 (XPO5). The pre-miRNA is then cleaved by Dicer to yield the
mature, double-stranded miRNA duplex. Following degradation of the passenger strand, the guide strand is incorporated into the miRNA-containing RNA-induced silencing
complex. Abbreviations: miRISC, miRNA-containing RNA-induced silencing complex; NPC, nuclear pore complex; pri-miRNA, primary transcript miRNA; pre-miRNA,
precursor miRNA.
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(UTR) of target mRNAs primarily through its 50 seed region
(positions 2–8). miRISC binding to the target’s miRNA recognition
element (MRE) leads to destabilisation and degradation in the
cytoplasmic processing bodies, or translational repression (inhibi-
tion of protein synthesis) in other cytoplasmic sites and
ribonucleoprotein granules (Goldie and Cairns, 2012). Although
rare in animals, perfectly matched target sequences are destroyed
directly through AGO2 mediated cleavage.
Both in vivo and in vitro stress models provide evidence for the
altered expression of miRNA biogenesis genes in response to stress.
Protein levels of dicer were reduced following in vitro culturing
with the ds-RNA viral mimic polyinosinic-polycytidylic acid (poly
I:C) and Interferon alpha (INF-a) (Wiesen and Tomasi, 2009).
Similarly, animal models of stress have demonstrated a decrease in
protein levels of the transcription factor REST (Repressor element-
1 silencing transcription factor) (Conaco et al., 2006; Uchida et al.,
2010), responsible for regulating the expression both pre- and
mature neural miRNA involved in prominent neuronal functions
such as brain development and plasticity (Conaco et al., 2006;
Uchida et al., 2010). Conversely, mice housed under environmental
enrichment conditions demonstrated increased levels of Dicer and
Ago2 combined with reduced anxiety-like behavior (Durairaj andKoilmani, 2014). Stress resilient mice have also been shown to
display b-catenin-associated Dicer upregulation (Dias et al., 2014).
MiRNAs are abundant in the human brain, having many diverse
and important roles in the development and function of the CNS,
including: neurogenesis (Maiorano and Mallamaci, 2009), migra-
tion, differentiation/speciﬁcation, (Sempere et al., 2004), regula-
tion of morphogenesis (Giraldez et al., 2005), axonogenesis,
synaptogenesis dendritic spine development (Schratt et al.,
2006) and myelination (Dugas et al., 2010). There are over 1800
human miRNAs listed in the miRNA database (miRBase Release
21.0) and collectively miRNA may regulate at least two-thirds of
the transcriptome. By affecting gene regulation, miRNAs are likely
to be involved in most biological processes, with small changes in
miRNA expression being able to ﬁne-tune the expression of
multiple genes within a biological network.
While the majority of miRNA sequences are conserved, a large
percentage of known miRNA are unique to primates, with many
unique to humans. These miRNA are thought to play a signiﬁcant
role in evolution and phenotypic variation between species. For
these more recently emerged miRNA, the lack of sequence
conservation for these molecules and their recognition sites in
the 30UTR of target genes, beyond primates, means there are
signiﬁcant implications for studies using non-primate animal
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use bioinformatics, cell model systems and perhaps in some
circumstance primate models.
3. MiRNA and the stress response
When stress occurs, these small but inﬂuential molecules are
ideally positioned to optimize stress responses through dynamic
modulation of gene expression via rapid and reversible responses.
However, regulation of the stress response requires a concerted
effort by numerous miRNA, including miRNA clusters and families,
and although initially a protective mechanism, stress-induced
alterations in miRNA expression are linked to neurodegeneration
and the pathogenesis of neurodegenerative diseases.
The complexity of miRNA function requires identiﬁcation of the
many genes that each miRNA targets and an understanding of the
context-speciﬁc factors that determine when and how these genes
are regulated. miRNA are able to regulate target genes directly
through interactions with both conserved and non-conserved
target recognition elements, which can lead to both a decrease and
increase in transcript abundance (Carroll et al., 2013, 2012). The
complexity of regulatory mechanisms involved in target recogni-
tion makes elucidation of the actual impact of individual miRNAs
very difﬁcult. In addition, there are other factors that can affect an
individual’s response to stress. For example, copy number
variations (CNVs) are associated with altered expression of
multiple genes and pathways and impact on miRNA-mediated
post-transcription regulatory networks, leading to an individual
difference in disease susceptibility (reviewed (Persengiev et al.,
2013)). Likewise, single-nucleotide polymorphism (SNP) interfer-
ence with miRNA functions affects the expression of corresponding
targets, modiﬁes brain functions and induces a risk of disease. A
recent study demonstrated that SNPs in miRNA-binding regions of
AChE could lead to alterations in downstream effects, increasing
inherited risks of anxiety and hypertension. Carriers of the
rs17228616 SNP minor allele, which impairs the primate-speciﬁc
regulation of AChE by miR- 608, show 60% higher brain AChE
activity compared with carriers of the major allele (Hanin et al.,
2014).
In addition, other factors such as ethnicity (Huang et al., 2011),
gender and age (Ziats and Rennert, 2013), can all inﬂuence miRNA
levels and therefore and individuals response to stress. Sex- biased
differences in microRNA expression have been found to inﬂuence
disease pathogenesis (Sharma and Eghbali, 2014) and miRNA
proﬁling has shown signiﬁcant alterations in the expression levels
of miRNA during aging. One of the most consistently observed
declines encountered during aging is stress attenuation: the
robustness of the response to stress is diminished in aged animals.
Therefore, the expression of miRNA needs to be balanced at the
proper threshold levels, allowing the avoidance of stress attenua-
tion (reviewed (Liang et al., 2009; Persengiev et al., 2013)). It is
therefore highly likely that all of these factors would have a
prominent role in an individual’s response to stress.
Furthermore, due to the complexity of miRNA–target inter-
actions, miRNA can affect an individual’s response to stress and
consequently their risk of inherited disease and disorders that may
occur due to an aberrant stress response. Therefore, the impor-
tance of genome information to human health and wellbeing
cannot be undervalued. Importantly, not only can miRNA be used
as biomarkers of disease, they are also now being recognized as a
promising therapeutic tool (Campbell and Booth, 2014; Gebert
et al., 2014; Scott et al., 2015), with the potential to yield a novel
class of therapeutics.4. MiRNA expression associated with acute stress
miRNAs are ideally positioned to coordinate the genomic
response to stress. These molecules have the ability to ensure
adaptation to environmental perturbations via rapid and reversible
responses. Emerging evidence in a number of model systems show
that miRNA are involved in the stress response (Supplementary
Table 1), with stress-induced modulation of miRNA expression and
changes in target gene expression affecting cytokine production,
receptor density, inﬂammation, neurotransmission and plasticity.
Additionally, exposure to environmental stressors has been
demonstrated to modulate the expression of both miRNA and
their biogenic machinery (Leung and Sharp, 2010; Meerson et al.,
2010; Mor et al., 2011; Uchida et al., 2008; Vasudevan et al., 2007;
Wiesen and Tomasi, 2009), capable of inducing long-lasting
behavioral adaption. This is supported by evidence suggesting
that miRNA modify experience-dependent neuronal plasticity,
through both short-term changes in neural transmission and gene
regulation, and long-term changes that lead to structural
modiﬁcations.
4.1. Psychological stress
Stress-induced alterations in miRNA expression can be region-
speciﬁc (Babenko et al., 2012; Rinaldi et al., 2010), with exposure to
stress affecting neural activity in different brain areas. For example,
let-7a, miR-9 and miR-26a/b had increased expression in the
frontal cortex, but not the hippocampus, of 10–12 week-old male
mice following acute restraint stress (Rinaldi et al., 2010). Similarly,
using a chronic stress/recovery paradigm, Babenko et al. (2012)
found that exposure of adult male rats to two weeks of mild
restraint stress signiﬁcantly downregulated miR-709 in the
cerebellum but not in the hippocampus or prefrontal cortex
(PFC). Alterations in expression of miR-709 in the cerebellum were
resistant to two-week long recovery from stress, however, in the
hippocampus and PFC, its expression was upregulated after two
weeks of recovery.
It is possible that changes in miRNA expression upon exposure
to environmental stressors may lead to altered neuronal morphol-
ogy and problems with neural circuitry. In a study by Meerson et al.
(2010), adult male rats subjected to both acute and chronic
immobilisation stress showed altered expression of numerous
miRNAs in two stress-responsive regions of the rat brain, the
hippocampal CA1 region and the central nucleus of the amygdala.
These miRNA have established brain or stress-related functions,
including miR-134, miR-17-5p and miR-124, involved in the
regulation of dendritic spine development and control of neuronal
development and differentiation (Beveridge et al., 2009; Schratt
et al., 2006; Yu et al., 2008), and miR-1, miR-132 and miR-182,
shown previously to be associated with stress (Shaked et al., 2009;
Simon et al., 2009). Importantly, miR-182 has been demonstrated
to regulate amygdala-dependent memory formation (Griggs et al.,
2013), while the miR-134 observation is especially noteworthy as
this molecule has a prominent role in synaptic plasticity and long-
term memory formation (Gao et al., 2010) and has altered
expression in schizophrenia (Gardiner et al., 2012; Santarelli
et al., 2011).
These animal models evoke emotional states related to fear and
anxiety, inducing anxiogenic-like effects in animals similar to
those observed in humans, with studies suggesting that this may
contribute fundamentally to the development and pathogenesis of
several psychiatric disorders, including mood disorders, schizo-
phrenia, and anxiety. For a detailed review on animal stress
models, see (Campos et al., 2013).
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4.2.1. Environmental pathogens
Exposure to environmental pathogens such as bacterial and
viral infections can alter miRNA expression, prompting an immune
response. Bacterial infections can induce the release of inﬂamma-
tory cytokines and the production of corticosteroids (glucocorti-
coids (GC)) from the hypothalamic- pituitary-adrenal (HPA) axis,
while viral infections can elevate systemic GC levels (Belkaya et al.,
2011). Murine glial cells cultured with the bacterial endotoxin
lipopolysaccharide (LPS) showed altered expression of miR-351,
miR-298, miR-146, miR-147 and miR-155 (Mor et al., 2011;
Ponomarev et al., 2010). These miRNA are involved in neuronal
differentiation (Cheng et al., 2009; Maiorano and Mallamaci, 2009;
Yu et al., 2008) and in the regulation of inﬂammatory pathways
(Liu et al., 2009; O’Connell et al., 2007; Sonkoly et al., 2008;
Taganov et al., 2006). Altered expression of these miRNA are
associated with neuropsychiatric disorders, including schizophre-
nia (Gardiner et al., 2012; Hebert et al., 2008; Lee et al., 2011;
Lehmann et al., 2012; Lukiw et al., 2008; Schipper et al., 2007).
Similarly, mice exposed to Japanese encephalitis virus (JEV), a
single-stranded, positive-sense RNA virus that causes Japanese
encephalitis, displayed a time-dependent increase in miR-155
expression. Correspondingly, expression of miR-155 was also
increased in JEV-infected human brain samples when compared to
the uninfected control (Thounaojam et al., 2014).
4.2.2. Cellular stressors
MiRNA levels have also been shown to be regulated by a variety
of cellular stressors such as oxidative stress, hypoxia, cold stress,
and nutrient deprivation (Hudder and Novak, 2008). For example,
hypoxic-ischemic brain injury in rats signiﬁcantly altered the
expression of miRNA, including mir-429, mir-200b, and mir-182
(Cui and Yang, 2013) and signiﬁcantly decreased miR-30a in mouse
cortical neurons (Wang et al., 2015). Glucose deprivation in human
glioblastoma cells led to a marked reduction in miR-451 levels.
Down-stream effects included the phosphorylation and activation
of AMPK and MARKs, leading to reduced cell proliferation; stress
responses leading to adaptation and cell survival; and increased
cell migration (Godlewski et al., 2010).
Sangiao-Alvarellos et al. (2014) demonstrated changes in
hypothalamic miRNA expression proﬁles in rats reared with a
high-fat diet (HFD), and caloric restriction (CR) during 3 months
after weaning. A HFD increased the expression of let-7a, mir-9,
mir-30b, mir-100a, and mir-145 while CR increased the expression
of mir-29a, mir-30e, mir-323-3p, and mir-374-5p, and decreased
the expression of mir-200a, mir-200b, and mir-200c. Furthermore,
mir-132, mir-218, and mir-539 showed increased expression with
either HFD or CR. Interestingly, they found a prominent effect on
miRNA families in response to nutritional challenge, including the
mir-30 family, the mir-200 family and the let-7 family.
4.2.3. Environmental chemicals
In humans, exposure to environmental chemicals is well known
to increase risks for various diseases and induce alterations in the
expression of many miRNA (Hou et al., 2011). These effects are also
observed in in vitro and animal models. For example, human
astroglial cells exposed to combined iron plus aluminum-sulfate
signiﬁcantly upregulated miRNA-125b and miRNA-146a expres-
sion, as well as reactive oxygen species (ROS) abundance and NF-k
B-DNA binding (Pogue et al., 2013). In the mouse brain, exposure to
hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX), a common environ-
mental contaminant, altered the expression of more than 100
miRNAs, including: let-7; miR-10b; miR-125a,b; miR-128; miR-
146b; miR-15a; miR-16, miR- 181a,b,d; miR-183; miR-191; miR-
195; miR-199a; miR-200a,b,c; miR-218; miR-222; miR-26b; andmiR-98 (Zhang and Pan, 2009). Let-7 and mir-98 are involved in
neuronal differentiation (Beveridge et al., 2009; Roush and Slack,
2008) and associated with the inﬂammatory response (Garbuzov
and Tatar, 2010); miR-146 is involved in the immune response
(Sonkoly et al., 2008; Meerson et al., 2010); miR-15 has a role in
neural processes and is associates with schizophrenia (Beveridge
et al., 2010) while miRs-200a, -200b and -200c have prominent
neuronal functions and are associated with the pathogenesis of
psychiatric disorders. Similarly, lead, another widespread heavy
metal contaminant in the environment, is a signiﬁcant neuro-
toxicant with exposure leading to altered neuronal development
and cognitive deﬁcits including learning and memory. Lead
exposure has also recently been associated with schizophrenia
(Guilarte et al., 2012). Speciﬁcally, male rats exposed to lead for
eight weeks in their drinking water displayed impairments in
spatial memory and altered hippocampal miRNA expression. These
miRNA included miR-204, miR-211, miR-448, miR-449a, miR-494,
miR-34b, and miR-34c, with pathway analysis predicting these
miRNA to be highly associated with neural injury and neuro-
degeration, axon and synapse function, and neural development
and regeneration (An et al., 2014).
4.2.4. Drugs of abuse
Substance abuse is widespread with around 15% of the
population using illicit drugs (Australian Institute of Health and
Welfare 2011, 2011). Exposure to drugs of abuse (such as cannabis,
cocaine, heroin and amphetamines) can lead to altered synaptic
plasticity and subsequent changes in behavior and psychological
function, such as learning and memory. This may occur through
alterations in miRNA, for example, dynamic changes in miRNA
expression were observed in rat hippocampus following repeated
cocaine exposure and subsequent abstinence from cocaine
treatment, including miR-133b, miR-134, miR-181c, miR-191,
miR-22, miR-26b, miR-382, miR-409-3p and miR-504 (Chen
et al., 2013). MiR-134 has a role in cholinergic neurotransmission
(Meerson et al., 2010), dendritic spine development (Schratt et al.,
2006) and hippocampal synaptic plasticity, long-term memory
formation (Gao et al., 2010). Similarly, rat primary hippocampal
neuron cultures and mouse hippocampi treated with the synthetic
opioid fentanyl resulted in the downregulation of miR-190 with
possible down-stream effects on neurogenesis and neuropatholo-
gy (Zheng et al., 2010).
Exposure to cannabinoid compounds, particularly during ado-
lescence, can induce long lasting changes in in both cognitive and
emotional behaviors (Pope et al., 2003; Trezza et al., 2012). Cannabis
exposure in healthy individuals is associated with: decreased adult
hippocampal neurogenesis; increased stress responsivity (Lee et al.,
2014); altered white matter microstructure (Baker et al., 2013; Bava
et al., 2009); increased dopamine neurotransmission (Bossong et al.,
2009); increased plasma cortisol levels and impaired working
memory (D’souza et al., 2004); and increased risk for psychotic
disorder (Boucher et al., 2010; D’souza et al., 2004; Henquet et al.,
2005; Long et al., 2010; Moore et al., 2007). In our recent study
(Hollins et al., 2014) we showed that rats exposed to the synthetic
cannabinoid HU210 during early adolescence displayed altered
miRNA expression during late adolescence (miR-23a-5p, miR-98,
miR-340-3p, miR-374,miR-300 -5p,miR-382-3pandmiR-499).MiR-
23 has been associated with autism spectrum disorders (Geaghan
and Cairns, 2014),miRs-23a and -98playa role in stress- inducedFas/
FasL-mediated apoptosis, critical to the development and homeo-
stasis of the immune system (Singh et al., 2012; Wang et al., 2011a,b),
and miR-340 is involved in pro-inﬂammatory immune responses
(Guerau-de-Arellano et al., 2012). It is possible that the miRNA
response to exogenous cannabinoid exposure may work to suppress
stress-induced inﬂammation by exerting immunosuppressive
effects via miRNA regulation of inﬂammatory targets (D’Addario
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infection, the number of miRNAs with altered expression was
increased, suggesting that an interaction of environmental insults
may enhance the miRNA response to stress (see Section 5.2).
5. MiRNA expression associated with prenatal stress
The developing brain is highly plastic and particularly sensitive
to environmental insults (reviewed (Dudley et al., 2011; Rice and
Barone, 2000)). Exposure to environmental stressors during this
critical period is known to lead to altered neurodevelopmental
processes resulting in differences in the adult brain, such as altered
neuronal morphology and problems with neural circuitry, that may
manifest as neuropsychiatric disorders (Dorph-Petersen et al.,
2007; Jakob and Beckmann, 1986; Schultz et al., 2011). Epidemio-
logical research suggests an association between gestational stress
and increased vulnerability in offspring to stress-related psycho-
pathological conditions (Khashan et al., 2008; Malaspina et al.,
2008). This includes nutrient deprivation, particularly deﬁciency in
folate and vitamins A and D; oxidative stress through smoking;
preterm birth or obstetric complications; recreational drug
exposure or fetal alcohol syndrome; in utero infection; and
psychosocial stress experienced by the mother and associated GC
exposure. Environment-genome interactions, therefore, are vital in
understanding how environmental risk factors can inﬂuence the
genome and subsequent neurodevelopmental processes.
Development of the mammalian brain is a highly controlled
process (Rice and Barone, 2000) requiring precise temporal and
spatial regulation of gene expression (Abramova et al., 2005; Stead
et al., 2006). By regulating mRNAs post- transcriptional fate,
miRNA play a signiﬁcant role in organising complex patterns of
gene activity. These small RNA molecules display distinct
expression proﬁles (Miska et al., 2004; Smirnova et al., 2005;
Smith et al., 2010), and exhibit both temporal and spatial speciﬁcity
that help to curate and buffer transcriptional output during
development (Kapsimali et al., 2007; Krichevsky et al., 2003; Miska
et al., 2004; Mukhopadhyay et al., 2011). Recent evidence suggests
that these molecules are both responsive and susceptible to
developmentally signiﬁcant environmental insults.
5.1. Maternal anxiety
There is increasing evidence that maternal anxiety is a key risk
factor for neurodevelopmental disorders. Complex interactions
between the maternal environment and the developing fetus can
result in alterations in prenatal programing associated with
psychiatric disorders such as schizophrenia. Stressful life events
that induce maternal anxiety, such as unwanted pregnancy, death of
a spouse or relative, war or natural disaster, are associated with
poorer memory and attention skills (Plamondon et al., 2014) as well
as an increased risk of schizophrenia in the offspring (reviewed
(Brown, 2011)). Correspondingly, there is vast experimental
evidence in animal models that maternal stress can induce
permanent alterations in fetal neurodevelopment and subsequent
offspring behavior (reviewed (Huizink et al., 2004; Ulupinar, 2009)).
These changes in offspring can persist into young adulthood and
include: altered microglial development, microglial differentiation
and number (Gómez-González and Escobar, 2010); impaired
hippocampal neurogenesis (Fujioka et al., 2006); impaired hippo-
campal-dependent spatial memory and hippocampal NMDA recep-
tor-mediated synaptic plasticity (Son et al., 2006); impaired HPA axis
activity (Barbazanges et al., 1996); altered HPA axis stress
responsiveness and anxious behavior (Brunton and Russell, 2010);
and altered responses to stressful situations (Fride et al., 1986)Recently, Zucchi et al. (2013) (carried out experiments in an
animal model which suggested miRNA expression is altered in
offspring following maternal exposure to psychological stress. Two
stressors, restraint of the body and forced swimming, were applied
to pregnant rats daily from gestational days 12–18, and miRNA
expression examined in whole brain of newborn offspring. A total
of 336 miRNA were identiﬁed as differentially expressed in
response to gestational stress, including the upregulation of
miR-103, miR-323, miR-98, miR-219 and the downregulation of
miR-145 as well as genes involved in development, axonal
guidance and neuropathology. Interestingly, miR-323 and miR-
98 are associated with the inﬂammatory response while miR-145
is a marker of the inﬂammatory disorder multiple sclerosis
(Guerau-de-Arellano et al., 2012) and is associated with bipolar
disorder (Kim et al., 2010). The miR-219 observation is particularly
interesting as this molecule is elevated in schizophrenia (Beveridge
et al., 2010) and has been demonstrated to target genes associated
with both schizophrenia and bipolar disorder including synapto-
tagmin V, netrin, and serine hydroxymethyltransferase (Coyle,
2009). This miRNA has also been shown to modulate excitatory
synaptic plasticity through N-methyl-D-aspartate (NMDA) gluta-
mate receptors (Kocerha et al., 2009; Wibrand et al., 2010), with a
disruption of NMDA receptor signaling demonstrated to reduce
levels of miR-219, inducing aberrant behavior in mice (Kocerha
et al., 2009). Interestingly, the NMDA-hypofunction model of
schizophrenia suggests that the disorder is associated with a loss of
NMDA receptors (Kehrer et al., 2008). A substantial decrease in
NMDA receptor subunits in synapses of the hippocampus, along
with signiﬁcant reductions in NMDA receptor-mediated long-term
potentiation, has been observed in maternally stressed offspring in
adulthood. Furthermore, both spatial learning and memory were
found to be signiﬁcantly impaired (Son et al., 2006). Together,
these observations suggest that maternal stress may modify the
expression of miR-219 in offspring, and thus alter neurodevelop-
mental plasticity, inducing neurobehavioral dysfunction and
possibly neuropsychosis.
5.2. Maternal immune activation
It is not well understood how maternal infection produces
abnormalities in offspring, however recent studies suggest that it
may be the maternal response to infection that plays a large role in
determining the responses of the offspring (Bronson et al., 2011;
Fatemi et al., 2011; Smith et al., 2007). Experimental evidence in
animal models indicates that following stress, the maternal
immune response, or maternal immune activation (MIA), results
in increased plasma corticosterone levels in pregnant dams. This,
along with increased maternal cytokine levels, are predicted to
mediate both the behavioral and transcriptional changes in
offspring following maternal infection and play a causal role in
the development of neuropathological conditions (Fatemi et al.,
2011; Smith et al., 2007). Evidence in animal models indicates that
maternal infection can induce long-lasting abnormalities in the
offspring including: impaired neuronal differentiation and hippo-
campal neurogenesis (Cui et al., 2009; Meyer et al., 2006);
impairments in hippocampal synaptic function, hippocampal
synaptic protein expression and short- and long-term plasticity
(Oh-Nishi et al., 2010); altered neural gene expression (Fatemi
et al., 2011; Smith et al., 2007); altered expression of genes
involved in the maturation of midbrain DA neurons and modulated
fetal dopaminergic development (Meyer et al., 2008). In addition,
infection in utero can lead to: increased vulnerability to stress in
adulthood (Fride et al., 1986); changes in offspring response to
drugs acting on dopaminergic and glutamatergic neurotransmitter
systems (Vorhees et al., 2015, 2012); increase the risk for relapse to
drug dependence (Richtand et al., 2012); and abnormalities in
S.L. Hollins, M.J. Cairns / Progress in Neurobiology 143 (2016) 61–81 67offspring behaviors similar to those seen in subjects with
schizophrenia (Smith et al., 2007; Wischhof et al., 2014; Wolff
and Bilkey, 2010, 2008).
Not surprisingly, MIA has been documented to be strongly
associated with an increased risk of offspring developing
schizophrenia (Brown and Derkits, 2010; Brown, 2012; Ellman
et al., 2010). However, studies suggest that multiple factors are
likely to be involved in the aetiology of neuropsychiatric disorders,
where early developmental disturbances enhance susceptibility to
neurological disorders, and the activation or ampliﬁcation of
symptoms occur only after a pathological response to a secondary
factor (Bayer et al., 1999; Maynard et al., 2001). To further
understand the role of miRNA in this process, we recently
examined the effects of MIA alone, and in combination with,
adolescent cannabis exposure on miRNA expression in the rat
entorhinal cortex (EC) (Hollins et al., 2014). Pregnant rats received
an intravenous injection of poly I:C or vehicle on gestational day
(GD) 15 and beginning post-natal day (PND) 35, select male
offspring were treated daily with the synthetic cannabinoid
HU210, or vehicle, for 14 days. MiRNA expression was examined
at late adolescence (PND 55). We found that prenatal poly I:C
caused signiﬁcant alterations in miRNA expression in the left
hemisphere of the EC, an effect that was strengthened by exposure
to HU210 during adolescence, with 72 miRNA found to have
signiﬁcantly altered expression levels (p < 0.05). A large subgroup
consisting of 20 miRNA was identiﬁed as being transcribed from a
single imprinted locus within the Dlk1-Dio3 domain in a cluster of
differentially expressed miRNAs on chromosome 6q32 (human
14q32/mouse 12qF1). It is possible that because of their involve-
ment in brain development and dendritic re-modeling, these
miRNAs may be involved in an adaptive response, altering neural
circuitry associated with environmental stressors. The role of
miRNA clusters in the stress response is discussed in further detail
in Section 8.
5.3. Fetal alcohol syndrome
Heavy alcohol consumption during pregnancy can result in the
development of Fetal Alcohol Syndrome (FAS), characterized by a
range of physical and mental defects in the fetus. The main effect of
FAS is permanent and irreversible damage to the CNS, in particular,
neuronal damage and structural abnormalities in the brain.
Phenotypes commonly associated with FAS include poor growth,
facial defects, cognitive impairment and behavioral problems.
Recent studies show a role for miRNA in the fetal response to
alcohol in utero. Using a murine model, Wang et al. (2009)
determined that prenatal ethanol exposure signiﬁcantly altered
expression of miRNA in fetal brain, including the upregulation of
miR-10a, miR-10b, miR-9, miR-145, miR-30a-3p and miR-152, and
downregulation of miR-200a, miR-496, miR-296, miR-30e-5p,
miR-362, miR-339, miR-29c and miR-154. In addition, they
observed that ethanol treatment also caused birth defects such
as intrauterine growth retardation, craniofacial dysmorphology
and brain abnormality, with offspring demonstrating intellectual
disabilities. Using a similar model, Laufer et al. (2013) demon-
strated global changes in miRNA expression in the adult brain of
offspring in response to both voluntary chronic ethanol exposure
and binge injections. In addition, the miRNAs that were affected
were speciﬁc to the developmental timing of alcohol treatment.
Interestingly, a large proportion were part of large miRNA clusters
encoded within three brain-speciﬁc imprinted regions of the
mouse genome. These clusters, Snrpn- Ube3a (Human 15q11–q13/
Murine 7qC) and Dlk1-Dio3 (Human 14q32/Rat 6q32/Murine
12qF1) and rodent speciﬁc Sfmbt2 (Murine 2qA1) are associated
with processes involved in neuronal plasticity and severalneurodevelopmental disorders. The Dlk1-Dio3 locus in particular
is discussed in further detail in Section 8.
5.4. Transgenerational effects of stress modulated by miRNA
While signiﬁcant offspring abnormalities are evident following
maternal stress, it is now evident that these effects may be passed
on to future generations. For example, exposure in utero to the
pesticide vinclozolin induces distinct transgenerational changes in
the brain transcriptome of F3 generation male animals that
correlated with alterations in behavior. Altered genes were found
to be relevant to behavior and neuropsychiatric disorders (Skinner
et al., 2008), suggesting a transgenerational role for miRNA in
regulating the genome. Indeed, this was shown to be the case in a
recent study by Yao et al. (2014), who provided evidence of
transgenerational epigenetic inheritance. In the study, pregnant
rats were stressed daily from GD 12 to GD 18 (a period thought to
cover a large extent of the human second trimester) by restraint
and forced swimming. Delayed developmental milestones were
observed in the F1 generation offspring, with an even stronger
impact in subsequent F2 and F3 generations. The multi-genera-
tional stress was found to induce drastic changes in neural miRNA
of the F2 generation. The altered miRNA, miR-23b, miR-96, miR-
141, miR-182, miR-183, miR-200a, miR-200b, miR-200c, miR-429
and miR-451, have prominent neuronal functions and are
associated with the pathogenesis of psychiatric disorders. In
particular, miR-182 has been demonstrated to regulate amygdala-
dependent memory formation (Griggs et al., 2013). In addition, the
expression of genes targeted by these miRNA was also altered,
including transcription regulators and mediators of neuropsychi-
atric disorders. These changes were accompanied by reduced
gestational length, an increase in blood glucose levels and delayed
behavioral development. Strikingly, it was the F3 offspring of
transgenerationally stressed mothers that exhibited the greatest
impact of prenatal stress, displaying low body weight, reduced
growth trajectories and delayed behavioral development. These
ﬁndings suggest a genuine role for the epigenetic inheritance for
the stress response through transgenerational programing of the
female germline.
Importantly, a recent study has shown that it is not only
maternal stress that can affect offspring. In a study by Rodgers et al.
(2013), male mice were exposed to six weeks of chronic variable
stress before breeding. Offspring of the paternally stressed mice
exhibited a signiﬁcantly blunted HPA stress axis response and
global gene pattern changes in transcription. Gene set enrichment
analyses identiﬁed increased expression of GC-responsive genes
within the PVN of the hypothalamus, consistent with altered
offspring stress responsivity. To uncover potential epigenetic
mechanisms of transmission, they examined miRNA expression in
the paternal sperm and identiﬁed nine miRNA as signiﬁcantly
increased (miRs-29c, -30a, -30c, -32, -193-5p, -204, -375, -532-3p,
-698). These miRNA are predicted to target DNMT3a, a DNA
methyltransferase that is required for genome-wide de novo
methylation and is essential for the establishment of DNA
methylation patterns during development. In a follow-up study
to conﬁrm causality of these miRNA changes in offspring neuro-
developmental programing, these nine miRNA in the sire’s sperm
were identiﬁed as a potential mechanism of epigenetic transmis-
sion. Speciﬁcally, following micro- injections of these nine miRNA
into single-cell zygotes, both male and female offspring mounted a
signiﬁcantly blunted corticosterone response to an acute restraint
stress as adults (Rodgers et al., 2015). Together, these ﬁndings
indicate that environmental factors, such as prenatal stress, can
cause transgenerational transmission of miRNA that modify
epigenetic proﬁles and offspring behavior associated with
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complex psychiatric and neurological disease pathogenesis.
6. MiRNA regulation of the stress response via the immune
system
While numerous studies demonstrate stress-induced dysregu-
lation of miRNA expression, understanding the role miRNAs play in
the regulation of stress- induced neuronal plasticity is of
paramount importance. MiRNAs are involved in the regulation
of innate immune responses (Sonkoly et al., 2008) and emerging
evidence now indicates a role for miRNA in regulating stress-
induced responses via the immune system. Dysregulation of the
immune system represents an important vulnerability factor for
psychosis, with inﬂammation a recognized precursor for neuropa-
thology (reviewed (Bergink et al., 2014)). In the mammalian brain,
activation of the inﬂammatory response system primarily occurs
due to the activation of glial cells (astrocytes and microglia) (Tyagi
et al., 2010a). Astrocytes are the most abundant glial cells in the
CNS, providing support by maintaining homeostasis and by
regulating neuronal signaling, survival and synaptic plasticity
(Mor et al., 2011). Microglia, macrophage-like cells resident within
the CNS, sense changes in the brain’s microenvironment and
accordingly act as the predominant form of active immune
defence. In response to inﬂammatory or other pathological
conditions, astrocytes and microglia leave their quiescent state
and become activated, releasing pro-inﬂammatory cytokines to
activate immune cells throughout the brain (Monji et al., 2009;
Mor et al., 2011). In fact, acute psychological stress has long been
known to stimulate production of a plethora of cytokines (Kaufer
and Soreq, 1999).
Glial cells play an important role in modulating the stress
response (Röhl et al., 2010), with exposure to stress demonstrated
to induce microglial activation (Hinwood et al., 2011a,b; Tynan
et al., 2010) and region-speciﬁc increases in microglial number
(Tynan et al., 2010). Gestational stress in animal models results in
offspring with accelerated microglial development, enhanced
microglial differentiation and increased microglial number in
the post-natal brain (Gómez-González and Escobar, 2010).
Microglial activation is a recognized precursor of pathology in
the CNS (reviewed (Carson et al., 2007)) and neuroinﬂammation is
associated with both neurological and neurodegenerative diseases
(Doorduin et al., 2009; Halleskog et al., 2011; Willard et al., 1999).
During gestation/early life, the activation of microglia by infection
or other environmental stressors can adversely affect processes
central for normal neuronal development, thereby setting the
stage for vulnerability for later psychotic disorders (reviewed
(Bergink et al., 2014; Meyer, 2011)). Later life exposure to an
environmental stressor could further activate microglia, leading to
functional abnormalities in neuronal circuitry and psychosis. In
addition, alterations in both the neural and immune systems play a
role in the pathophysiology of chronic pain, which has cognitive,
emotional and behavioral components. As miRNAs regulate
immune and neuronal processes, it is highly likely that they too
are involved, as speciﬁc miRNAs have been associated with
pathological pain in rodent pain models. Evidence also suggests
that miRNA may also have a role in the response to pain, and to the
responsiveness and tolerance to medications (reviewed (Kress
et al., 2013)).
Controlling neuroinﬂammation is considered a promising
approach to treat neurodegenerative disorders, therefore, under-
standing the role of miRNA in regulating stress-induced inﬂam-
matory responses could have signiﬁcant therapeutical beneﬁts. In
this section we will discuss the role of miRNA in modulating the
stress response via three key mechanisms: TLR signaling; the
cholinergic anti-inﬂammatory pathway; and the HPA axis. BothTLR signaling and the cholinergic anti-inﬂammatory pathway
regulate the innate immune response (innate immunity), while the
HPA axis controls reactions to the immune system and the
response to stress.
6.1. TLR signaling
Activation of both microglia and astrocytes in response to
foreign pathogens occurs via TLR signaling (Jack et al., 2005). TLRs
are key pattern recognition receptors that facilitate a tailored
response to environmental signals, enabling direct modulation of
the immune response (Jack et al., 2005; Olson and Miller, 2004).
Although innate immunity in the CNS depends primarily on the
function of glial cells, especially astrocytes and microglia, there is
strong evidence to suggest TLRs are also expressed on neurons,
having dynamic expression levels inﬂuenced by various mediators.
TLR activation leads to the induction of proinﬂammatory cytokines
and activation of MAPK family members involved in gene
transcription. In addition to its role in modulating immune
responses, TLR signaling is thought to have an important role in
neurogenesis, with accumulating evidence indicating a role in
tissue development, cellular migration, differentiation, and repair
processes (reviewed (Trudler et al., 2010)).
Over activation of TLRs has been linked to neurodegeneration
and the pathogenesis of neurodegenerative diseases (Kielian,
2006; Trudler et al., 2010), therefore, this signaling pathway must
be tightly regulated to maintain homoeostasis. MiRNA most likely
play an important role in achieving this critical balance between
immunity and pathological tissue damage. Indeed, let-7 has
recently been identiﬁed as a strong activator of TLR signaling in
microglia and neurons, with TLR activation by this miRNA inducing
dose- and time-dependent neuronal cell death (Lehmann et al.,
2012). Expression levels of several members of the let-7 family
(let-7a, -7c, -7f and miR-98) have been observed following both
prenatal and postnatal exposure to stress (Supplementary Table 1).
In addition, a number of studies using a variety of stress paradigms
have shown both temporal and spatial regulation of the TLR-
induced miR-9 in the brain. This miRNA is increased: in fetal mouse
brain following in utero ethanol exposure (Wang et al., 2009); in
the whole brain of newborn rats following gestational stress; in the
frontal cortex of ten-week old mice following acute restraint stress
(Rinaldi et al., 2010); and in the medial prefrontal cortex of ten-
week old rats following chronic restraint stress (Uchida et al.,
2010). However, in adult rats, miR-9 expression was found to
decrease in the amygdala and hippocampus following both acute
and chronic restraint stress (Meerson et al., 2010).
Similarly, astrocytes cultured in vitro with the LPS and the
cytokine interferon-gamma (IFN-g) increased their expression of
known TLR-induced miRNAs, miRs-146, -147 and -155 (Mor et al.,
2011). These miRNA are demonstrated to negatively regulate the
activation of inﬂammatory pathways by regulating TLR signaling
and the ensuing cytokine response (Liu et al., 2009; O’Connell et al.,
2007; Sonkoly et al., 2008; Taganov et al., 2006). In the same study,
the mouse and rat-speciﬁc miRs-351 and -298, predicted to be
involved in the regulation of genes involved in the tumour-necrosis
factor-alpha (TNF-a) signaling pathway and the increased secre-
tion of IL-6, had their expression downregulated (Mor et al., 2011).
Expression levels of miR-298 were also decreased in the amygdala
of an animal model of chronic immobilisation stress (Meerson
et al., 2010).
Microglia activated by culturing in vitro with LPS and IFN-g
downregulated expression of miR-124, an abundant, brain-speciﬁc
miRNA normally highly expressed by microglia (Ponomarev et al.,
2010). This miRNA has a role in neuronal differentiation during
both CNS development and adult neurogenesis (Cheng et al., 2009;
Maiorano and Mallamaci, 2009; Yu et al., 2008). Altered expression
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et al., 2008; Lehmann et al., 2012; Lukiw et al., 2008; Schipper et al.,
2007), Huntington’s disease (Lee et al., 2011) and schizophrenia
(Gardiner et al., 2012). Together, these ﬁndings support the
possibility of stress-induced chronic or sustained inﬂammatory
responses inducing long-lasting alterations in miRNA expression
leading to altered neuronal development.
6.2. The cholinergic anti-inﬂammatory pathway
Studies suggest that miRNA regulation plays a critical role in
balancing cholinergic neurotransmission (Nadorp and Soreq,
2014). In the CNS, the cholinergic anti-inﬂammatory pathway
can regulate the innate immune response, providing a braking
effect by inhibiting the production of proinﬂammatory cytokines
via signaling through nicotinic acetylcholine receptors (nAChRs).
Interestingly, current research indicates cholinergic modulation of
microglial activation through the a7 nAChR subunit (CHRNA7)
expressed on microglia (Shytle et al., 2004), with the inhibition of
proinﬂammatory cytokine production via signaling through
CHRNA7 demonstrated to protect the brain against inﬂamma-
tion-induced tissue damage (Pavlov et al., 2009; Rosas-Ballina and
Tracey, 2009; Tyagi et al., 2010b; Wang et al., 2003).
Innervation of the cholinergic system increases cholinergic
activity, releasing acetylcholine (ACh), the principal neurotrans-
mitter of brain cholinergic neurons, into the synaptic cleft where it
binds to nAChRs on the post-synaptic membrane (Pavlov et al.,
2009; Rosas-Ballina and Tracey, 2009; Tyagi et al., 2010b; Wang
et al., 2003). Following the use of restraint stress, miR-1 was
demonstrated to be upregulated in both the amygdala and
hippocampus of adult male rats (Meerson et al., 2010). This
miRNA has been shown to regulate nAChR subunit abundance as
well as the expression of the transcription factor MEF-2, resulting
in altered pre-synaptic ACh secretion (Simon et al., 2009).
Intriguingly, MEF-2 has been shown previously to regulate the
miRNA cluster imprinted on chromosome 14q32 (see also Section 8
below) (Fiore et al., 2009) and was recently shown to be directly
modulated by MIA via major histocompatibility class I molecules,
resulting in reduced cortical synapse density in offspring (Elmer
et al., 2013). MEF-2 isoforms have been shown to regulate multiple
aspects of synaptic development (Flavell et al., 2008) indicating a
role for MEF-2 modulation of miRNA expression in modulating
neuronal plasticity in response to stress.
Cholinergic neurotransmission is terminated via the hydro-
lyzation of ACh by acetylcholinesterase (AChE) (Pavlov et al., 2009;
Rosas-Ballina and Tracey, 2009; Salpeter, 1967; Wang et al., 2003).
In the mammalian brain, acute psychological stress induces
hyperexcitation of cholinergic neurotransmission and rapid, long
lasting increases in AChE gene expression. Several studies have
conﬁrmed that both the transcriptional activation and activity of
AChE are altered under stress conditions, with experimental
evidence supporting the notion that miRNA play a role in this
process. Speciﬁcally, miR-134 and miR-183 were upregulated
under conditions of acute immobilisation stress in both the
amygdala and hippocampus of adult male rats, while under
conditions of chronic immobilisation stress, miR-134 expression
was downregulated in both brain regions and miR-183 expression
remained unchanged (Meerson et al., 2010). Both miRNA were
demonstrated to modulate the expression of the serine/arginine-
rich splicing factor 2 (SFRS2) (Meerson et al., 2010), a pre-mRNA
splicing factor that regulates the stress-induced alternative
splicing of AChE mRNA in neurons (Soreq and Seidman, 2001).
Following stress exposure, SFRS2 mediates long-term alternative
splicing of AChE gene expression, affecting the local regulation of
cholinergic neurotransmission (Meshorer et al., 2005).The study by Meerson et al. (2010) also found increased levels of
hippocampal miR-132 following chronic immobilisation stress.
This miRNA has been demonstrated to directly regulate AChE
activity (Meerson et al., 2010; Shaked et al., 2009) and to have
signiﬁcantly increased expression levels following exposure to a
variety of stress paradigms. For example, Shaltiel et al. (2012)
demonstrated signiﬁcantly increased hippocampal miR- 132
expression levels in mice that were accompanied by a reduction
in hippocampal AChE following both exposure to predator scent
and foot-shock stress. Uchida et al. (2010) demonstrated that
following early maternal separation, exposure of eight-week old
rats to two weeks of chronic restraint stress signiﬁcantly increased
expression levels of both pre-miR-132 and mature miR-132 in the
medial prefrontal cortex (mPFC), and that expression of miR-132
remained upregulated in the adult rat.
Collectively, these studies suggest a role for miRNA in the
stress-induced regulation of the cholinergic response via modula-
tion of AChE activity. Indeed, studies suggest that stress exposure
can alter body–brain signaling through cell-mediated ACh
hydrolysis, leading to changes in miRNA expression and a decrease
in the levels of AChE, potentiating ACh signaling, and exacerbating
anxiety (Meshorer and Soreq, 2006; Shaltiel et al., 2012; Soreq,
2015). As AChE has been demonstrated to enhance neurite growth
and synapse development (Sternfeld et al., 1998), not surprisingly,
AChE imbalances are associated with neuropathology and
neurological disease (Meshorer and Soreq, 2006; Soreq and
Seidman, 2001). Indeed, miR-134 has been demonstrated to
regulate hippocampal synaptic plasticity, long-term memory
formation (Gao et al., 2010) and dendritic spine development
(Schratt et al., 2006) while miR-132 has been shown to regulate
dendritic maturation, neurogenesis (Magill et al., 2010; Wayman
et al., 2008) and synapse formation (Luikart et al., 2011).
Overexpression of miR-132, as seen in these studies, has been
demonstrated to induce an anti- inﬂammatory molecular expres-
sion (Luikart et al., 2011), to increase dendritic spine density and is
associated with neuronal developmental abnormalities (Hansen
et al., 2010). It is conceivable that stress-induced alterations in
cholinergic activity via miRNA activity may result in chronic
inﬂammation, leading to the cognitive impairments associated
with neuropsychiatric disorders as cholinergic innervation has
been demonstrated to inﬂuence spatial learning (Fish et al., 2004).
Chronic neuroinﬂammation can have cytotoxic effects on cholin-
ergic cells within the CNS (Willard et al., 1999) with cholinergic
mechanisms thought to underlie the progressive neurodeteriora-
tion characteristic of several neurodegenerative disorders (Kaufer
and Soreq, 1999).
Neuroinﬂammatory modulation of the cholinergic system is
also thought to be a major factor in the pathophysiology of
epilepsy. Unprovoked seizures affect more than 50 million people
worldwide. Rodent models of epilepsy have demonstrated an
association between cholinergic dysfunction and epilepsy, includ-
ing upregulation of AChE, which was linked to an enhanced
immune response and facilitation of the epileptogenic process
(Gnatek et al., 2012). Emerging evidence suggests a role for miRNA
in this process, with experimental models demonstrating a unique
miRNA signature in whole blood that differed from trauma, stroke
and haemorrhage, including up-regulation of miR-21, miR-34a,
miR-132, miR-146a, miR-155, miR-199a and miR-375. In particular,
miR-132 regulates AChE activity (Meerson et al., 2010; Shaked
et al., 2009), while miR-146a has been shown to regulate
expression of toll-like receptors (TLRs) and cytokine pathways
(Sonkoly et al., 2008) (reviewed (Jimenez-Mateos and Henshall,
2013) and (Henshall, 2014)).
Given the potential signiﬁcance of miRNA in mediating the
brains response to inﬂammation through the ACh system, it is
important to reﬂect on the conservation of this interaction, with a
Fig. 2. Activation of the hypothalamic- pituitary-adrenal (HPA) axis Exposure to
stress causes secretion of corticotropin-releasing hormone (CRH) by the
hypothalamus; CRH release stimulates secretion of adrenocorticotrophic hormone
(ACTH) from the pituitary gland where it acts on the adrenal gland to stimulate the
release of glucocorticoid hormones (CORT). CORT then acts on the anterior pituitary
and the hypothalamus in a negative feedback system.
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target genes involved in ACh synthesis and degradation were
primate-speciﬁc (Nadorp and Soreq, 2014). As discussed in
Section 2, this could have signiﬁcant implications for studies
using animal models as well as for their potential to yield a novel
class of therapeutics.
6.3. The HPA axis
Emerging evidence suggests a role for cholinergic receptors and
ACh in regulating the HPA axis (Bugajski et al., 2007), the principal
neuroendocrine stress response system. In response to stress,
parvocellular neurons of the paraventricular hypothalamus (PVN)
increase secretion of corticotropin-releasing hormone (CRH; also
known as CRF), which is released into portal vessels activating
secretion of adrenocorticotrophic hormone (ACTH) from anterior
pituitary cells. In turn, ACTH enters the circulation and stimulates
the release of GCs, cortisol in humans and corticosterone in
rodents, from the adrenal gland (Fig. 2). Interestingly, ACh has been
shown to stimulate hypothalamic CRH secretion (Calogero et al.,
1988), with stress being a critical trigger for the initiation of
chronically elevated CRH levels in humans. Stressor-enhanced GC
secretion, as part of the HPA axis response to stress, is a sign of
health and promotes behavioral adaptation. Nonetheless, these
signaling events must be tightly controlled in order to avoid an
exaggerated stress response. In healthy individuals, exposure to a
stressor elicits a negative-feedback regulation of the HPA axis
involving the release of GCs (de Kloet et al., 2009), modulating a
wide range of adaptations, including anxiety-like behaviors.
However, dysregulation of the HPA axis has been associated with
several psychiatric disorders such as depression, panic disorder,
posttraumatic stress disorder and schizophrenia (Jansen et al.,
2000; Ströhle and Holsboer, 2003).
Several studies have reported stress-induced alterations in
miRNA expression levels affecting regulation of HPA axis activity.
Following both acute and chronic stress exposure, Haramati et al.
(2011) reported the upregulated expression of two members of the
prominent stress-induced miR-34 family, miR-34a and miR-34c, in
the amygdala of adult male mice. Additional in vitro studies
demonstrated that miR-34c reduced the responsiveness of cells to
CRH in neuronal cells endogenously expressing corticotropin
releasing hormone receptor 1 (CRHR1). Additionally, miR-34c was
found to regulate CRHR1 transcript, which has previously been
demonstrated to modulate anxiety-like behavior (Heinrichs and
Koob, 2004). In accordance with these observations, overexpres-
sion of miR-34c in the amygdala of adult male mice was
demonstrated to induce anxiolytic properties which were more
pronounced after a stressful event (Haramati et al., 2011). These
ﬁndings are in line with evidence suggesting that many
fundamental symptoms characteristic of depression are most
likely mediated by CRH (Holsboer,1998) and suggest a role for miR-
34c in mediating stress-induced anxiety via HPA regulation.
Alterations in mir-34 expression are also associated with
Parkinson’s disease (Miñones-Moyano et al., 2011) and schizo-
phrenia (Kim et al., 2010) and increased hippocampal expression of
miR-34c is suggested to play a role in memory impairment
(Zovoilis et al., 2011).
The synthesis and release of CRH and ACTH are inhibited by GCs
acting through two types of receptors: the glucocorticoid receptor
(GR) and the mineralocorticoid receptor (MR). These two receptors
are part of a feedback loop that involves the activation and
transporting of the CORT receptor complexes, ultimately affecting
transcriptional outcome. Within the limbic system, MRs maintain
stability and protect neural networks, control threshold/sensitivity
of thestress response,activateglutamatereleaseinthehippocampusand amplify the stress reaction (de Kloet et al., 2009). The GRs
moderate hippocampal neuronal maturation and neurogenesis as
well as acting as transcriptional regulators, inhibiting transcription
of genes involved in the innate immune response (Fujioka et al.,
2006). Importantly, the level of cellular GRs determines the cell’s
responsiveness to the circulating GCs (de Kloet et al., 2009), which
are increased following stress exposure (Gómez-González and
Escobar, 2010; Uchida et al., 2008). Recent studies indicate that
miRNA play a role in this process with miR-124 and miR-18
demonstrated to post-transcriptionally regulate expression levels of
GR protein in the brain (Uchida et al., 2008; Vreugdenhil et al., 2009).
The expression of both miRNA is altered following stress exposure.
Chronic early-life stress induced upregulated expression of miR-124
in the mPFC of 14-day-old rats, with upregulation persisting into
adulthood (Uchida et al., 2010). However, in adult rats, expression of
miR-124 is decreased in the amygdala following acute stress (foot-
shock) (Mannironi et al., 2013), in the hippocampus following acute
immobilisation stress (Meerson et al., 2010) and in whole brain
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and mature miR-18 expression levels were increased in the PVN of
the hypothalamus in nine-week old rats following chronic restraint
stress, accompanied by signiﬁcantly reduced GR protein (Uchida
et al., 2008). These ﬁndings suggest an early-response mechanism
that persists into adulthood, whereby GR protein levels are
decreased in response to early-life stress, reducing the cell’s
responsiveness to GCs. This response may protect the brain from
neuropathology, as excess levels of GCs can induce dendritic
retraction (Wellman, 2001) while blockade of GRs has been
demonstrated to inhibit stress-induced dendritic retraction (Fujioka
et al., 2006; Liu and Aghajanian, 2008; Vreugdenhil et al., 2009). GR
activation has been demonstrated to suppress miR-132 expression
resulting in a decrease in glutamate receptors and brain-derived
neurotrophic factor (BDNF) (reviewed (Schouten et al., 2013)),
associated with the survival of cholinergic synapses in the rat
forebrain (Fish et al., 2004). Additionally, overexpression of miR-
135a has been demonstrated to reduce the expression of MR by more
than 60% using a luciferase assay in HeLa cells. Acute stress in adult
mice signiﬁcantly decreased the expression of miR-135a in the
amygdala, which was accompanied by a three-fold increase in MR
protein levels (Mannironi et al., 2013).
The interaction of GCs and CRH with their respective receptors
during critical periods of brain maturation can alter the
programing of the fetal HPA axis (Ulupinar, 2009), and stress-
induced alterations in GC levels and GR/MR activity via miRNA
regulation could be responsible for alterations in neuronal
development and an increased susceptibility to later psychopa-
thology. Indeed, maternal stress during pregnancy has been
demonstrated to increase plasma GC levels in the fetus leading to a
downregulation of fetal GR and MR, in turn, impairing the
feedback regulation of the HPA axis in the offspring. Alterations in
these stress hormones can affect both the morphology and
function of limbic system structures in offspring leading to deﬁcits
in both mood and cognitive behaviors (reviewed (Weinstock,
2005)).
7. Analysis of differentially expressed miRNA from a variety of
stress paradigms
To gain further insight into how miRNA might exert their
inﬂuence following stress exposure, miRNA differentially
expressed in a variety of stress paradigms (Supplementary Table 1)
were analyzed to identify putative target genes using the Ingenuity
Pathway Analysis (IPA) Software Tool (Ingenuity Systems). These
target genes were assessed for enrichment in gene ontology (GO)
categories and involvement in biologic pathways using the Gene
Annotation Tool to Help Explain Relationships (GATHER; available
at http://gather.genome.duke.edu/) (Chang and Nevins, 2006) and
IPA, which maps biomolecular networks based on known signaling
pathways and known interactions with reliable data curation.
Functional analysis conﬁrmed that stress-induced alterations in
miRNA expression could affect a multitude of biological systems.
For example, these miRNA are highly predicted (p < 0.0001) to
regulate genes involved in development, neurogenesis, cell
proliferation, Wnt receptor signaling, neurophysiological process
and the defence response (Supplementary Table 2). Additionally,
functional analyses identiﬁed 35% of miRNA as likely to be involved
in TLR signaling (Table 2). Pathway analyses of the target gene lists
identiﬁed the MAPK signaling; oxidative phosphorylation; focal
adhesion; adherens junction and Wingless/int (WNT) signaling
pathways as being signiﬁcantly (p < 0.0001) highly enriched
(Table 3). In particular, the MAPK and WNT signaling pathways
are involved in microglial function, cholinergic signaling and HPA
axis function and are discussed below.7.1. Stress-induced microRNA regulation of MAPK and WNT signaling
pathways
Both MAPK and WNT signaling feature prominently in the
regulation of microglial function (Koistinaho and Koistinaho,
2002), and play a role in regulating the stress response via both
cholinergic signaling and initiation of the HPA axis. Recent studies
in several neuronal models suggest both the WNT signaling and
MAPK pathways play a crucial role in nicotinic cholinergic
signaling (Tang et al., 1998), indicating a role in the stress
response. Both pathways are involved in regulating the expression
(Farías et al., 2007; Kim et al., 2013), translocation (Jensen et al.,
2012) and function (Farías et al., 2007) of nAChRs during activity-
dependent synaptic plasticity and the MAPK pathway is itself
activated by nAChRs (reviewed (Dajas-Bailador and Wonnacott,
2004)). In microglial cells challenged with LPS, the neurotrans-
mitter ACh is able to regulate TNF-a production via regulation of
MAPKs phosphorylation (Shytle et al., 2004). This is most likely
achieved through the binding of ACh to CHRNA7 on microglia and
the subsequent inhibition of proinﬂammatory cytokine production
(see Section 6.2). The nAChRs signiﬁcantly contribute to multiple
facets of brain function, including neuronal development, learning
and memory; therefore dysregulation of this system could have
deleterious effects on cognitive functioning.
There is also an established relationship between the stress-
induced activation of the HPA axis and the MAPK and WNT
signaling pathways. MAPK signaling can be initiated via stress-
induced overexpression of CRH and subsequent activation of the
CRHR1, resulting in decreased MAPK phosphorylation and
increased GC secretion (Bonﬁglio et al., 2011). GCs are proposed
to markedly decrease proliferation and neuronal differentiation
while promoting glial cell formation via the WNT signaling
pathway (Moors et al., 2012). WNT signaling stimulation of
microglia can induce activation of MAPK extracellular signaling
which in turn mediates the WNT-induced transformation of
microglia (Halleskog et al., 2012). In microglia, the powerful WNT
signaling cascade initiates proinﬂammatory microglial transfor-
mation and accentuates pathogenic impact (Halleskog et al., 2011).
Importantly, along with it’s role in neuronal maturation and
plasticity, MAPK signaling is crucial for memory consolidation
(Hebert and Dash, 2002; Samuels et al., 2008), therefore,
alterations to this pathway may induce cognitive deﬁcits, in
particular memory impairments. In line with these ﬁndings,
postmortem human studies show a disruption of the MAPK
pathway in schizophrenia (Kyosseva et al., 1999). Accordingly, a
series of human and animal studies suggest that antipsychotic
dugs used in the treatment of psychiatric disorders such as
schizophrenia may provide long-term beneﬁts through their
ability to regulate the MAPK signaling pathway with subsequent
modulation of neuroplasticity (reviewed (Ishima et al., 2012;
Molteni et al., 2009).
7.2. Stress-induced microRNA regulation of the endocannabinoid
system
Analysis of the miRNA in Supplementary Table 1 identiﬁed 49
stress- induced miRNA that are predicted to target genes with
biological roles in all aspects of endocannabinoid (eCB) signaling
(Table 4). Throughout both pre- and post-natal life the eCB system
is vital in brain organisation. During fetal development there is a
functional eCB system in the CNS (in both humans and animal),
with functional CB1 receptors (PND 11-14 in rats and gestational
week 19 in humans) at levels higher than those in the adult brain
(Berrendero et al., 1998; Mato et al., 2003). In the brain, eCBs are
neurotransmitters, acting as agonists for the CB1 receptor. This
receptor is thought to play an important role in modulating adult
Table 1
miRNA clusters and families altered by stress.
Cluster/Family miRNA
Cluster 1 miR-182, miR-183, miR-96
Cluster2 miR-134, miR-369, miR-381, miR-382, miR-410
Cluster 3 miR-15, miR-16
Cluster 4 miR-376a, miR376b, miR-376c, miR-381
miR-154 family miR-323, miR-369, miR-381, miR-382, miR-410
miR-17 family miR-17, miR-106b
miR-221 family miR-221, miR-222
miR-368 family miR-376a, miR-376b, miR-376c
let-7 family let-7a-1, let-7c, let-7f-1, let-7f-2
Table shows miRNA clusters and families altered following restraint stress in adult
male rats in a study by Meerson et al. (2010).
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glutamate activity via retrograde eCB signaling (Di et al., 2003). The
eCB system is a neuroactive lipid signaling system that functions to
gate synaptic transmitter release and plays a functional role in
sustaining a protective and healthy CNS microenvironment
(Eljaschewitsch et al., 2006). In response to enhanced neuronal
activity, eCBs are recruited by the nervous system where they
suppress synaptic glutamate release (Di et al., 2003), playing an
important role in mediating the brain’s response to stress and
modifying anxiety-like behaviors (Campos et al., 2010). The eCB
system acts locally to affect multiple systems, with eCB signaling
activated ‘on demand’, regulating the function of both the immune
and nervous systems (Tanasescu et al., 2012).
7.2.1. Endocannabinoid signaling and the HPA axis
For example, eCB signaling through CB1 receptors plays a vital
role in the regulation of the HPA axis, an intricate system that
exhibits both simple and complex means of regulation and exerts
both rapid and delayed effects on neuronal function. Acute
restraint stress has been demonstrated to induce activated GR-
mediated increases in hippocampal eCB signaling, as well as eCB-
dependent modulation of GABA release (Wang et al., 2012). In
contrast, chronic stress leads to GC-activation of GRs and a
functional downregulation of presynaptic CB1 receptors within the
PVN, resulting in impaired eCB signaling at GABA and glutamate
synapses (Wamsteeker et al., 2010). In addition to these studies,
there is a substantial body of research which suggest a biphasic
relationship between stress and the eCB system, with eCB signaling
regulating both the activation and termination of the HPA axis in
response to stress (Hill et al., 2010). Increased eCB signaling during
acute stress may help maintain homeostatic systems, however, the
loss of eCB signaling following chronic stress exposure could
contribute to the development of stress-related psychiatric
disorders such as depression, panic disorder, posttraumatic stress
disorder and schizophrenia (Jansen et al., 2000; Ströhle and
Holsboer, 2003).
7.2.2. Endocannabinoid signaling and cholinergic neurotransmission
Similarly, eCBs may exert their inﬂuence through modulation of
cholinergic neurotransmission. In the brain, the release of ACh is
inhibited by eCBs and conversely, CB1 receptor blockade increases
ACh release (Gifford and Ashby, 1996). Studies indicate that
activation of muscarinic acetylcholine receptors (mAChRs) ini-
tiates the production and release of eCBs that bind to CB1 receptors
located on synaptic terminals (Alger et al., 2014; Rinaldo and
Hansel, 2013). Acute exposure to the environmental toxins
parathion and chlorpyrifos (organophosphorus insecticides) has
been found to inhibit AChE as well as FAAH, the enzyme primarily
responsible for metabolic degradation of AEA, leading to substan-
tial increases in extracellular eCBs in the rat hippocampus (Liu
et al., 2013). In addition, exposure to acute stress induces enhanced
mAChR-mediated eCB mobilization and increased eCB hippocam-
pal content (Wang et al., 2012).
Studies also suggest that the eCB system, via direct or indirect
interaction with the cholinergic system, may be responsible for
inducing deﬁcits in spatial learning and memory (Robinson et al.,
2010) and in the modulation of depression- related behavior (Kruk-
slomka et al., 2015). A study by Goonawardena et al. (2010) found
that administration of the synthetic cannabinoid WIN55,212-2
(WIN-2) induced signiﬁcant deﬁcits in short-term memory
performance that was accompanied by a reduced ﬁring rate in
pyramidal neurons. After administering an AChE inhibitor, the
memory deﬁcits were reversed and the hippocampal ﬁring rates
normalized, demonstrating that WIN-2-induced deﬁcits in mem-
ory performance are due to inhibited cholinergic activation within
the hippocampus.7.2.3. Endocannabinoid signaling and the immune response
Microglial cells express cannabinoid receptors (Waksman et al.,
1999) and when activated can produce larger quantities of eCBs
than neurons or astrocytes (Walter et al., 2003). Eljaschewitsch
et al. (2006) found that activation of the eCB system during CNS
inﬂammation induces a negative feedback loop in microglial cells
to protect neurons from inﬂammatory damage. This feedback
system acts via eCB receptor-mediated regulation of the anti-
inﬂammatory protein dual speciﬁcity phosphatase 1 (DUSP1; also
known as MKP-1) expression (Eljaschewitsch et al., 2006). This
family of proteins are pivotal in the regulation of immune
responses, with DUSP1 in particular having a central role in
immune regulation (Liu et al., 2007) via a negative feedback effect
that represses MAPK-mediated pro-inﬂammatory signaling path-
ways and cytokine secretion. DUSP1 is thought to play an
important role in the human cellular response to environmental
stress as well as in the negative regulation of cellular proliferation.
Two miRNA, miR-32 (Meerson et al., 2010) and let-7a (Meerson
et al., 2010; Rinaldi et al., 2010), with observed expression changes
following stress exposure (Supplementary Table 1), are predicted
to regulate the expression of DUSP1. These ﬁndings suggest a role
for miRNA in regulating stress responses and inﬂammation
through eCB signaling via the HPA axis, the cholinergic anti-
inﬂammatory pathway, microglia and the MAPK signaling
pathway.
8. Coordinated miRNA activity in the stress response
Regulation of the stress response requires a concerted effort,
demonstrated by recent evidence showing alterations in expres-
sion of miRNA clusters and family members. MiRNA clusters (Fig.1)
are generated as polycistronic primary transcripts (pri-miRNAs),
functioning in combination to carry out their many roles (Lagos-
Quintana et al., 2003; Lee et al., 2002). MiRNA with the same seed
(position 2–8 from the 50 end of the mature miRNA) are designated
as belonging to a miRNA family, and usually perform similar, if not
the same, functions. A recent study by Meerson et al. (2010)
identiﬁed stress-induced changes in miRNA expression in the
hippocampus and central amygdala of adult rats. Using a model of
restraint stress, the study investigated the involvement of miRNA
in regulating region-speciﬁc stress-induced changes in alternative
splicing in adult male rats. However, closer examination of their
data reveals stress-induced alterations in expression of many
miRNA clusters and families (Table 1). Of particular interest are the
miRNA in the miR-154 and miR-368 families, structurally
associated by their genomic position on the long arm of
chromosome 14 (14q32). Signiﬁcantly, this locus is known as
the DLK1-DIO3 region and is imprinted such that the associated
miRNA cluster is expressed only from the maternal chromosome
(Royo and Cavaillé, 2008). These miRNA are predicted to have an
important role in brain function and development (Fiore et al.,
2009; Kim et al., 2004; Manakov et al., 2009) and accordingly have
Table 2
Stress-induced miRNA regulation of TLR-signaling.
Gene
Name
Description Stress-induced differentially expressed miRNA
CD14 CD14 molecule miR-
208
CHUK conserved helix-loop-helix ubiquitous kinase let-7a miR-
146a
miR-23a
ELK1 ELK1, member of ETS oncogene family miR-
186
FOS FBJ murine osteosarcoma viral oncogene homolog miR-
221
miR-
29a
IKBKB inhibitor of kappa light polypeptide gene enhancer in B-cells,
kinase beta
miR-
15b
IRAK1 interleukin-1 receptor-associated kinase 1 miR-
146a
miR-
134
IRAK2 interleukin-1 receptor-associated kinase 2 miR-
146a
miR-
15b
miR-
532-3p
IRAK3 interleukin-1 receptor-associated kinase 3 miR-
124
IRAK4 interleukin-1 receptor-associated kinase 4 miR-
106b
JUN jun proto-oncogene miR-
15b
miR-
30a
LBP lipopolysaccharide binding protein miR-
146a
MAP2K3 mitogen-activated protein kinase kinase 3 miR-
19a
miR-
21
miR-9 miR-
96
MAP2K4 mitogen-activated protein kinase kinase 4 miR-
124
miR-
137
miR-145 miR-
15b
miR-
22
miR-
29a
miR-
32
MAP2K6 mitogen-activated protein kinase kinase 6 miR-
29a
MAP3K1 mitogen-activated protein kinase kinase 1, E3 ubiquitin protein
ligase
let-7a miR-
124
miR-351 miR-
137
miR-
106b
miR-
18a
miR-
21
miR-
23a
miR-
26a
miR-
30a
miR-
9
MAP3K14 mitogen-activated protein kinase kinase 14 miR-
137
miR-
106b
miR-19a
MAP4K4 mitogen-activated protein kinase kinase 4 let-7a miR-
145
miR-23a miR-
29a
miR-
30a
miR-
34c
miR-
96
MAPK1 mitogen-activated protein kinase 1 miR-
124
miR-
132
miR-15b miR-
106b
miR-
186
miR-
19a
miR-
204
miR-
26a
miR-
410
miR-
32
MAPK11 mitogen-activated protein kinase 11 let-7a
MAPK12 mitogen-activated protein kinase 12 miR-
351
MAPK13 mitogen-activated protein kinase 13 miR-
34c
MAPK14 mitogen-activated protein kinase 14 miR-
124
miR-
351
miR-19a miR-
22
NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-
cells 1
miR-9
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-
cells inhibitor, alpha
miR-
381
PPARA peroxisome proliferator-activated receptor alpha let-7a miR-
124
miR-351 miR-
106b
miR-
19a
miR-
21
miR-
22
miR-
9
RELA v-rel avian reticuloendotheliosis viral oncogene homolog A miR-
124
TAB1 TGF-beta activated kinase 1/MAP3K7 binding protein 1 miR-
134
TAB2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 let-7a
TICAM2 toll-like receptor adaptor molecule 2 miR-
186
TLR1 toll-like receptor 1 miR-
146a
TLR10 toll-like receptor 10 miR-
146a
TLR4 toll-like receptor 4 let-7a miR-
145
miR-
146a
TLR5 toll-like receptor 5 miR-
19a
TLR6 toll-like receptor 6 miR-
204
miR-
382
TLR8 toll-like receptor 8 miR-
22
TLR9 toll-like receptor 9 miR-
146a
TNFAIP3 tumour necrosis factor, alpha-induced protein 3 let-7a miR-
103
miR-351 miR-
106b
miR-
18a
miR-
19a
miR-
23a
miR-
29a
TOLLIP toll interacting protein miR-
106b
miR-
298
TRAF4 TNF receptor-associated factor 4
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Table 2 (Continued)
Gene
Name
Description Stress-induced differentially expressed miRNA
miR-
29a
miR-
370
TRAF6 TNF receptor-associated factor 6, E3 ubiquitin protein ligase miR-
124
miR-
351
miR-
146a
miR-
15b
Putative gene targets of differentially expressed miRNA in Supplementary Table 1 were identiﬁed using IPA. Table lists target genes identiﬁed by IPA as involved in TLR
signaling.
Table 3
Putative pathways regulated by stress-induced miRNA.
KEGG Pathway No. Genes Bayes Factor p-value
MAPK signaling pathway 179 21.38 <0.0001
Oxidative phosphorylation 31 18.65 <0.0001
Focal adhesion 170 18.05 <0.0001
Wnt signaling pathway 111 13.48 <0.0001
Adherens junction 64 11.99 <0.0001
Regulation of actin cytoskeleton 145 7.88 <0.0001
Tryptophan metabolism 27 7.17 <0.0001
Insulin signaling pathway 101 5.92 <0.0001
Table lists pathways identiﬁed by GATHER as signiﬁcantly enriched in the putative
miRNA target gene set based on Bayes factor >6 as recommended (Chang and Nevins
2006). Putative gene targets of differentially expressed miRNA in Supplementary
Table 1 were identiﬁed using IPA.
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et al., 2003), anxiety (Middeldorp et al., 2008) and fetal alcohol
syndrome (Laufer et al., 2013). We have recently shown that this
region is associated with MIA (Hollins et al., 2014) and is altered in
peripheral blood mononuclear cells (PBMCs) from individuals with
schizophrenia (Gardiner et al., 2012). This very large miRNA cluster
evolved relatively recently emerging in eutherian mammals.
Interestingly, expression of the long non-coding precursor RNA
derivative of these miRNA is also highly sensitive to synaptic
activity and displays coordinated upregulation in response to
neural excitation by modulation of the calcium activated Myocte
Enhancer Factor 2 (MEF2) transcription factor (Fiore et al., 2009).
This suggests that the resident miRNAs are important for synaptic
function. It is therefore quite signiﬁcant that the MEF2C member of
this family has been shown to be genetically associated with
schizophrenia in the latest genome wide association study (Ripke
et al., 2014). MEF2C has also been implicated in inﬂammation
responses through activity-dependent Major histocompatibility
complex class I (MHCI) signaling, leading to changes in synapse
density in cortical neurons (Elmer et al., 2013).
Also of interest are the let-7 and mir-17 families involved in the
regulation of development and neuronal differentiation (Beveridge
et al., 2009; Roush and Slack, 2008). In addition, let-7 family
members play a conserved role in mediating the inﬂammatory
response through inhibition of the proinﬂammatory cytokine
interleukin-6 (IL-6) (Garbuzov and Tatar, 2010), while the miR-17
family is involved in the regulation of the mitogen-activated
protein kinase (MAPK) signaling pathway (Beveridge et al., 2009;
Wu et al., 2012), a pathway known to be dysregulated in
schizophrenia (Kyosseva et al., 1999). Alterations in expression
of these miRNA could lead to alterations in neuronal processes as
well as the increased secretion of proinﬂammatory cytokines,
possibly via toll-like receptor (TLR) signaling (see Section 6.1),
leading to subsequent neuropathology.
A similar study by Haramati et al. (2011) found members of the
miR-15 family (miRs-15a, -15b) and the miR-34 family (miRs-34a,
-34c) were signiﬁcantly upregulated in the central amygdala of
adult male mice following restraint stress. The miR-15 family
regulate the expression of genes involved in cell division,metabolism and the stress response (Finnerty et al., 2010) and
are associated with Alzheimer’s Disease (Hébert et al., 2010; Wang
et al., 2011a,b) and schizophrenia (Beveridge et al., 2010). Similarly,
members of the miR-34 family target mRNAs important in cell
cycle progression and cell survival, the innate immune response
(O’Connell et al., 2010), and are associated with both Huntington’s
Disease (Gaughwin et al., 2011) and Alzheimer’s Disease (Schipper
et al., 2007). Certainly, miRNA families most likely play a key role in
moderating the central stress response within different brain
regions via the regulation of genes mediating both the behavioral
and physiological changes required to restore homeostasis.
However, although initially a protective mechanism, stress-
induced alterations in miRNA expression could have deleterious
effects on the mammalian brain.
9. Conclusions and perspectives
In this review we have drawn on the current evidence to
support a physiological role for miRNAs in regulating the central
stress response. However, as this is a relatively new ﬁeld of
investigation, it is likely that further evidence will emerge
conﬁrming the role of miRNA in stress-mediated functions as
well as stress-induced neuropathological conditions. Multiple
studies have shown that miRNA expression is altered following
exposure to both pre- and post-natal environmental stressors.
These alterations can be accompanied by morphological, physio-
logical and behavioral abnormalities. MiRNA functions in stress
responses involve numerous feedback systems and signaling
pathways. These stress-mediated functions can lead to changes
in neural structure, circuits, plasticity and cognition, manifesting
as neurodevelopmental or neurodegenerative disorders. Remark-
ably, some studies suggest that the responses to these experiences
induced by changes in miRNA are transmitted between gener-
ations, with signiﬁcant transgenerational alteration of miRNA
expression and neurobehavioral sequelae in the F3 generation. As
the majority of studies investigate the effects of acute stress or
maternal stress, it is highly likely that the potential outcomes are
more detrimental and wide reaching than what is currently
known. While the molecular mechanisms underlying miRNA-
mediated responses remain unclear, the available data suggest a
crucial role for miRNA in the response to environmental stress.
Further investigation to elucidate these mechanisms is required in
order to understand the causal relationship between miRNA
regulation of the stress response and neuropathology. With
mounting evidence that miRNA serve as biomarkers of disease,
continuing research in this area may lead to novel miRNA-based
therapies for the prevention and/or treatment of neurodevelop-
mental and neuropathological disorders.
Translational research which seek to further understand the
role of miRNA in the brains response to stress, particularly in
human subjects or primate models, will provide a clear platform
for the stress related miRNA biomarkers and therapeutic strategies
that can modulate miRNA biogenesis and function. Despite the
signiﬁcant problems in delivering nucleic acid based drugs,
Table 4
Stress-induced miRNA regulation of the endocannabinoid system.
MiRNA Target endocannabinoid mRNA
let-7a Napepld, Trpa1
let-7c Napepld, Trpa1
let-7f Napepld, Trpa1
miR-9 Drd2, Ptgs2, Ptpn22
miR-15a Napepld
miR-15b Napepld
miR-17 Cnr1, Mgll, Napepld
miR-18a Grm1, Naaa
miR-19a Cnr1, Grm1, Napepld, Ppara
miR-22 Daglb, Grm5, Gpr55, Trpv4
miR-23a Cnr1, Grm5, Trpa1
miR-26a Cnr1, Napepld, Ptgs2
miR-26b Cnr1, Napepld, Ptgs2
miR-29a Abhd4, Cnr1, Nat1
miR-30a Cnr1, Dagla, Grm3, Grm5, Trpa1
miR-32 Faah2, Grm1, Ptpn22
miR-34c-5p Gpr55, Pparg, Trpv4
miR-96 Grm1, Grm5, Pparg, Trpa1
miR-106b Cnr1, Mgll, Napepld
miR-124 Napepld, Trpv1, Trpv4
miR-132 Cnr1, Faah2, Grm3, Grm5, Ptgs2
miR-134 Cnr1, Mgll
miR-138 Faah2
miR-146a Ptgs2, Cnr1
miR-148a Mgll, Ptgs2
miR-155 Napepld, Ptpn22
miR-182 Abhd4, Grm1, Grm4, Grm5, Mgll, Pparg, Trpa1
miR-183 Grm1, Dagla, Ptgs2, Ptpn22
miR-186 Faah2, Grm5, Napepld, Ptpn22, Trpa1, Trpv1
miR-190 Grm5, Ptpn22
miR-193a-3p Ptpn22
miR-193b Ptpn22
miR-202 Ptgs2, Trpa1
miR-208a Faah2
miR-208b Faah2
miR-212 Cnr1, Faah2, Grm3, Grm5, Ptgs2
miR-216b Cnr1, Grm1, Grm5, Trpa1
miR-221 Cnr1, Grm1
miR-222 Cnr1, Grm1
miR-330-5p Drd2
miR-361-5p Grm1, Grm5, Pparg, Ptpn22
miR-370 Grm4
miR-376a Grm3, Napepld
miR-376b Grm3, Napepld
miR-381 Cnr1, Grm1, Grm3, Grm5, Ptgs2
miR-382 Cnr1, Grm1, Nat2, Napepld
miR-410 Cnr1, Grm1, Grm2, Nat1, Ptgs2
miR-422a Trpv4
miR-424 Napepld
Putative gene targets of differentially expressed miRNA in Supplementary Table 1
were identiﬁed using IPA. Table lists target genes identiﬁed by IPA as involved in TLR
signaling.
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exploring the potential for gene-delivered miRNA and miRNA
antagonists for more speciﬁc interventions to this system. There
have also been signiﬁcant advances in the production and delivery
of synthetic miRNA and miRNA antagonists that are modiﬁed by
cell membrane penetrating peptides and other moieties. Other
formulations using synthetic encapsulating lipid vesicles and even
biological vesicles, such as exosomes, can be engineered with
tropism for neural tissue that can facilitate the delivery of its gene
regulating cargo through the blood brain barrier (Alvarez-Erviti
et al., 2011). While the challenges of small molecule and nucleic
acid based approaches to miRNA therapeutics are signiﬁcant, these
remain important new and inﬂuential targets for therapeutic
manipulation of the neural stress responses.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.
pneurobio.2016.06.005.
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